Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Verona Pharma Plc ADR shares valued at $1,014,343 were sold by Rickard Kathleen A. on May 06 ’25. At $8.82 per share, Rickard Kathleen A. sold 114,984 shares. The insider’s holdings dropped to 2,546,472 shares worth approximately $168.73 million following the completion of this transaction.
Also, KATHLEEN RICKARD purchased 14,373 shares, netting a total of over 1,038,449 in proceeds.
Before that, Rickard Kathleen A. had sold 49,200 shares from its account. In a trade valued at $440,350, the Chief Medical Officer traded Verona Pharma Plc ADR shares for $8.95 each. Upon closing the transaction, the insider’s holdings decreased to 49,200 shares, worth approximately $174.48 million.
As published in their initiating research note from TD Cowen on April 28, 2025, Verona Pharma Plc ADR [VRNA] has been a Buy and the price target has been revised to $100. Analysts at Cantor Fitzgerald started covering the stock with ‘”an Overweight”‘ outlook in a report released in late April. As of January 10, 2025, ROTH MKM has initiated its “Buy” rating for VRNA. Earlier on October 03, 2024, Wells Fargo initiated its rating. Their recommendation was “an Overweight” for VRNA stock.
Analyzing VRNA Stock Performance
During the last five days, there has been a drop of approximately -8.30%. Over the course of the year, Verona Pharma Plc ADR shares have jumped approximately 42.68%. Shares of the company reached a 52-week high of $74.18 on 04/29/25 and a 52-week low of $43.44 on 01/10/25. A 50-day SMA is recorded $63.97, while a 200-day SMA reached $44.85.
Support And Resistance Levels for Verona Pharma Plc ADR (VRNA)
According to the 24-hour chart, there is a support level at 63.89, which, if violated, would cause prices to drop to 61.51. In the upper region, resistance lies at 69.32. The next price resistance is at 72.37. RSI (Relative Strength Index) is 51.57 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.46, which suggests the price will decrease in the coming days. Percent R is at 51.76%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
